Macrovascular events after kidney-pancreas transplantation in type 1 diabetic patients

Transplantation Proceedings

Volumn 35, Issue 5, 2003, Pages 2019-2020

  Naf S ^a   Ricart, M José ^a   Recasens, M ^a   Astudillo, E ^b   Fernandez Cruz L ^b   Esmatjes, E ^a,c  

^a INST D INVESTIGACIONS B   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Endocrinology and Diabetes Unit   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AMPUTATION; ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INTERMITTENT CLAUDICATION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PANCREAS TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; SMOKING; STROKE;

EID: 0041330503     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00711-5     Document Type: Conference Paper

References (5)

1. Biesenbach G., Margreiter R., Königsrainer A., et al. Diabetologia. 43:2000;231.
2. Elliott M., Kapoor A., Parker M., et al. Circulation. 104:2001;563.
3. Fiorina P., La Rocca E., Venturini M., et al. Diabetes. 50:2001;496.
4. La Rocca E., Fiorina P., Astorri E., et al. Cell Transplant. 9:2000;929.
5. Morrisey P.E., Shaffer D., Monaco A.P., et al. Arch Surg. 132:1997;358.